siRNA-mediated inactivation of HER3 improves the antitumour activity and sensitivity of gefitinib in gastric cancer cells.
Yuan HH, Yang YN, Zhou JH, Li YJ, Wang LY, Qin JW, Liu T, Li ZZ, Zhou QX, Wei XL, Zhang TT, Huang P, Zhang WJ, Liu L, Du XX, Han Y.
Yuan HH, et al. Among authors: yang yn.
Oncotarget. 2017 Apr 29;8(32):52584-52593. doi: 10.18632/oncotarget.17526. eCollection 2017 Aug 8.
Oncotarget. 2017.
PMID: 28881753
Free PMC article.